Data and Information
The programme, which is focused on providing preventive and personalised healthcare for citizens of the United Arab Emirates, wants more citizens to offer samples.
From drug discovery to forecasting kidney disease AI could be the next game-changer in healthcare.
The new capital boosts Olive’s valuation to $4 billion.
The “first of its kind” institution aims at enhancing local genomic research, and diagnosing and treating patients with genetic disorders. Its launch coincides with the formation of the board of the Emirati Genome Program.
The industry has accepted that digital is here to stay, with 87% of executives saying their organization’s business and technology strategies are becoming inseparable.
While mHealth apps collect and share user data less often than other types of apps, researchers say these apps have serious privacy problems.
The new venture is backed by a $34 million Series A round led by Andreessen Horowitz (a16z).
Payors can leverage Smarter Health and Health Catalyst's combined solution in ensuring the appropriate cost of care.
HIMSS21
At HIMSS' State of Healthcare event on June 15, Oscar CEO Mario Schlosser will discuss how the insurance space has adjusted to the COVID-19 demands.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.